NCT05332717

Brief Summary

This randomized controlled trial (RCT) will compare the effects of melatonin vs. placebo in patients undergoing primary total knee arthroplasty (TKA). This RCT aims to study the effects melatonin has on sleep quality after TKA. Patients will be blinded to their respective groups and will be instructed to take either 5mg melatonin or a placebo pill (Vitamin C) for 6 weeks postoperative. Sleep quality surveys will be administered preoperatively and post-operative week 6, 90-days and 1 year. Poor sleep quality is a common issue faced by patients undergoing TKA. The goal of this study is see if melatonin can improve postoperative sleep quality, and if so, does improved sleep quality correlate to improvements in other postoperative outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
176

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

January 10, 2022

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 18, 2022

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
Last Updated

September 14, 2023

Status Verified

September 1, 2023

Enrollment Period

21 days

First QC Date

August 10, 2021

Last Update Submit

September 12, 2023

Conditions

Keywords

MelatoninArthroplastyKneeSleep

Outcome Measures

Primary Outcomes (4)

  • Sleep Quality

    Assessed based on self-reported data collected using the Pittsburgh Sleep Quality Index (PSQI). Minimum Score: 0; Maximum Score: 21. Higher scores indicate a worse outcome.

    Preoperatively

  • Sleep Quality

    Assessed based on self-reported data collected using the Pittsburgh Sleep Quality Index (PSQI). Minimum Score: 0; Maximum Score: 21. Higher scores indicate a worse outcome.

    6-week

  • Sleep Quality

    Assessed based on self-reported data collected using the Pittsburgh Sleep Quality Index (PSQI). Minimum Score: 0; Maximum Score: 21. Higher scores indicate a worse outcome.

    90 days

  • Sleep Quality

    Assessed based on self-reported data collected using the Pittsburgh Sleep Quality Index (PSQI). Minimum Score: 0; Maximum Score: 21. Higher scores indicate a worse outcome.

    1-year

Secondary Outcomes (8)

  • Knee Function

    Preoperatively, 6-week, 90-day and 1-year follow-up

  • Lower Extremity Activity

    Preoperatively, 6-week, 90-day and 1-year follow-up

  • Overall Health

    Preoperatively, 6-week, 90-day and 1-year follow-up

  • Pain Ratings

    Preoperatively, 6-week, 90-day and 1-year follow-up

  • Opioids Prescribed

    90-day follow-up

  • +3 more secondary outcomes

Study Arms (2)

Melatonin Group (Experimental)

EXPERIMENTAL

Patients who will take one (1) 5mg Melatonin tablet 30 minutes before bedtime daily for the 6 weeks following surgery.

Dietary Supplement: Melatonin 5 mg

Placebo Group (Control)

SHAM COMPARATOR

Patients who will take one (1) placebo (Vitamin C) tablet 30 minutes before bedtime daily for the 6 weeks following surgery.

Dietary Supplement: Placebo (Vitamin C)

Interventions

Melatonin 5 mgDIETARY_SUPPLEMENT

Participants will be taking one 5 mg tablet of Melatonin 30 minutes before bedtime nightly, for 6 weeks following their knee replacement surgeries.

Melatonin Group (Experimental)
Placebo (Vitamin C)DIETARY_SUPPLEMENT

Participants will be taking one placebo tablet 30 minutes before bedtime nightly, for 6 weeks following their knee replacement surgeries.

Placebo Group (Control)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing primary, unilateral TKA
  • Primary diagnosis of osteoarthritis (OA)
  • Aged 18+
  • Subject is opioid naive (has not taken opioids during the 6 months prior to surgery)
  • Subject is not currently taking sleep medication
  • English speaking
  • Has working email (for survey purposes)

You may not qualify if:

  • Patients with diagnosis other than OA including: Inflammatory arthritis; Post-traumatic OA; Chronic pain; Insomnia\*; Depression\*; Anxiety\*; Any active sleep disorder
  • Planned contralateral knee or subsequent total joint arthroplasty within 90 days
  • Any planned surgery within 90 days
  • Patient taking medication for depression or insomnia or anxiety during the 6 months prior to surgery
  • Patients with renal or hepatic disorders as these can affect melatonin metabolism
  • Insomnia, anxiety, and depression will be defined as use of controlled medication for that disorder which will be identified in istop or HSS record of the patient filled in the 6 months prior to surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital for Special Surgery

New York, New York, 10021, United States

Location

Related Publications (6)

  • Shakya H, Wang D, Zhou K, Luo ZY, Dahal S, Zhou ZK. Prospective randomized controlled study on improving sleep quality and impact of zolpidem after total hip arthroplasty. J Orthop Surg Res. 2019 Sep 3;14(1):289. doi: 10.1186/s13018-019-1327-2.

    PMID: 31481074BACKGROUND
  • Mammoto T, Fujie K, Taguchi N, Ma E, Shimizu T, Hashimoto K. Short-Term Effects of Early Postoperative Celecoxib Administration for Pain, Sleep Quality, and Range of Motion After Total Knee Arthroplasty: A Randomized Controlled Trial. J Arthroplasty. 2021 Feb;36(2):526-531. doi: 10.1016/j.arth.2020.08.018. Epub 2020 Aug 18.

    PMID: 32900564BACKGROUND
  • Kirksey MA, Yoo D, Danninger T, Stundner O, Ma Y, Memtsoudis SG. Impact of Melatonin on Sleep and Pain After Total Knee Arthroplasty Under Regional Anesthesia With Sedation: A Double-Blind, Randomized, Placebo-Controlled Pilot Study. J Arthroplasty. 2015 Dec;30(12):2370-5. doi: 10.1016/j.arth.2015.06.034. Epub 2015 Jun 21.

    PMID: 26173613BACKGROUND
  • Luo ZY, Li LL, Wang D, Wang HY, Pei FX, Zhou ZK. Preoperative sleep quality affects postoperative pain and function after total joint arthroplasty: a prospective cohort study. J Orthop Surg Res. 2019 Nov 21;14(1):378. doi: 10.1186/s13018-019-1446-9.

    PMID: 31752947BACKGROUND
  • Hemati K, Pourhanifeh MH, Dehdashtian E, Fatemi I, Mehrzadi S, Reiter RJ, Hosseinzadeh A. Melatonin and morphine: potential beneficial effects of co-use. Fundam Clin Pharmacol. 2021 Feb;35(1):25-39. doi: 10.1111/fcp.12566. Epub 2020 Jun 21.

    PMID: 32415694BACKGROUND
  • Oh ES, Leoutsakos JM, Rosenberg PB, Pletnikova AM, Khanuja HS, Sterling RS, Oni JK, Sieber FE, Fedarko NS, Akhlaghi N, Neufeld KJ. Effects of Ramelteon on the Prevention of Postoperative Delirium in Older Patients Undergoing Orthopedic Surgery: The RECOVER Randomized Controlled Trial. Am J Geriatr Psychiatry. 2021 Jan;29(1):90-100. doi: 10.1016/j.jagp.2020.05.006. Epub 2020 May 16.

    PMID: 32532654BACKGROUND

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

MelatoninAscorbic Acid

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

TryptaminesIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsHormonesHormones, Hormone Substitutes, and Hormone AntagonistsSugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydrates

Study Officials

  • Alejandro G Della Valle, MD

    Hospital for Special Surgery, New York

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will not be informed if they are receiving study drugs or placebo pills. Placebos will be compounded to be identical to treatment drugs in shape, size, color, texture etc.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study will compare postoperative sleep quality in two groups of patients undergoing primary total knee arthroplasty (TKA): * Group 1 will take melatonin during the 6 week postoperative period * Group 2 will take a placebo during the 6 week postoperative period
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2021

First Posted

April 18, 2022

Study Start

January 10, 2022

Primary Completion

January 31, 2022

Study Completion

April 30, 2022

Last Updated

September 14, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

IPD will not be made available at the study conclusion due to its inclusion of Protected Healthcare Information (PHI).

Locations